Show
Sort by
-
- Journal Article
- A1
- open access
Overall survival and exploratory biomarker analyses of abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus chemotherapy in HR+, HER2+ metastatic breast cancer patients
-
- Journal Article
- A1
- open access
KLRG1 cell depletion as a novel therapeutic strategy in patients with mature T-cell lymphoma subtypes
-
- Journal Article
- A1
- open access
Biological sample collection to advance research and treatment : a fight osteosarcoma through European research and Euro Ewing Consortium statement
-
- Journal Article
- A1
- open access
Clinical characteristics and outcomes of central nervous system tumors harboring NTRK gene fusions
-
- Journal Article
- open access
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
-
- Journal Article
- A1
- open access
ENIGMA CHEK2gether Project : a comprehensive study identifies functionally impaired CHEK2 germline missense variants associated with increased breast cancer risk
-
Zoledronic acid add-on therapy for standard-risk Ewing sarcoma patients in the Ewing 2008R1 trial
-
Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis
-
- Journal Article
- A1
- open access
Phase I/IIa trial of BMS-986148, an anti-mesothelin antibody–drug conjugate, alone or in combination with nivolumab in patients with advanced solid tumors
-
- Journal Article
- A1
- open access
Pembrolizumab monotherapy for previously untreated advanced hepatocellular carcinoma : data from the open-label, phase II KEYNOTE-224 trial